|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,268.10 INR | +0.86% |
|
-0.19% | +7.39% |
| 06-05 | Lupin Gets US FDA Approval for Ranluspec Interchangeable Biosimilar for Eyesight Ailments | MT |
| 06-04 | Lupin Limited Receives Approval from U.S. FDA for Ranluspec Ranibizumab Injection | CI |
Chart calendar Lupin Limited
Upcoming events on Lupin Limited
No events available
Past events on Lupin Limited
| 08/05/2026 | Earnings presentation | 11:30 |
| 07/05/2026 | Earnings release - Q4 2026 | |
| 07/05/2026 | Board of Directors Meeting | 09:15 |
| 13/02/2026 | Extraordinary General Meeting | |
| 13/02/2026 | Earnings presentation | 10:30 |
| 12/02/2026 | Earnings release - Q3 2026 | |
| 12/02/2026 | Board of Directors Meeting | |
| 07/11/2025 | Earnings presentation | 10:30 |
| 06/11/2025 | Board of Directors Meeting | |
| 06/11/2025 | Earnings release - Q2 2026 | |
| 25/09/2025 | Extraordinary General Meeting | |
| 11/08/2025 | Présentation aux Actionnaires / Analystes | 11:30 |
| 11/08/2025 | Annual General Meeting | 11:30 |
| 06/08/2025 | Earnings presentation | 11:30 |
| 05/08/2025 | Earnings release - Q1 2026 | |
| 05/08/2025 | Board of Directors Meeting | 12:30 |
Past dividends on Lupin Limited
| 25/07/2025 | Ex-dividend date - 12 INR | 05:00 |
Annual results
| Fiscal Period | March | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 166 417 163 950 1.5% | 200 108 198 661 0.73% | 227 079 225 466 0.72% | 279 580 271 633 2.93% | 296 474 | 312 225 |
|
EBITDA Million INR | Released Forecast Spread | 17 206 17 156 0.29% | 38 000 36 412 4.36% | 52 775 52 342 0.83% | 81 595 76 986 5.99% | 75 810 | 76 425 |
|
EBIT Million INR | Released Forecast Spread | 8 399 8 726 -3.75% | 26 032 26 419 -1.46% | 41 083 41 705 -1.49% | 67 840 63 989 6.02% | 60 498 | 60 198 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 7 165 7 215 -0.7% | 24 223 25 289 -4.22% | 40 150 40 797 -1.59% | 68 726 65 245 5.33% | 61 295 | 62 542 |
|
Net income Million INR | Released Forecast Spread | 4 301 3 940 9.17% | 19 145 19 781 -3.22% | 32 816 32 000 2.55% | 53 328 49 018 8.79% | 45 983 | 46 864 |
|
EPS INR | Released Forecast Spread | 9,41 8,74 7.62% | 41,9 43,3 -3.2% | 71,7 70,7 1.4% | 116 109 7.02% | 101 | 103 |
| Announcement Date | 09/05/23 | 06/05/24 | 14/05/25 | 07/05/26 |
Quarterly results
| Fiscal Period | March | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 50 386 48 189 4.56% | 51 974 48 810 6.48% | 49 608 50 871 -2.48% | 56 003 52 383 6.91% | 56 727 55 353 2.48% | 57 677 56 799 1.55% | 56 671 55 687 1.77% | 62 583 63 749 -1.83% | 65 708 | 67 755 | 69 566 | 79 093 | 78 401 | 75 383 | 75 009 |
|
EBITDA Million INR | Released Forecast Spread | 9 231 8 076 14.31% | 10 220 8 705 17.4% | 9 968 9 950 0.18% | 12 864 10 633 20.98% | 13 083 12 098 8.14% | 13 659 12 820 6.54% | 12 921 12 465 3.66% | 16 414 16 681 -1.6% | 17 829 | 18 779 | 19 001 | 23 723 | 21 734 | 20 050 | 17 302 |
|
EBIT Million INR | Released Forecast Spread | 6 753 5 627 20% | 7 648 5 621 36.06% | 5 397 7 472 -27.77% | 10 387 7 954 30.59% | 10 514 9 134 15.1% | 10 944 10 090 8.46% | 8 989 9 796 -8.24% | 13 424 13 496 -0.54% | 14 872 | 16 322 | 16 404 | 19 145 | 17 087 | 15 908 | 12 683 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 6 297 5 462 15.28% | 7 361 5 626 30.84% | 4 977 6 435 -22.66% | 9 930 7 331 35.45% | 10 549 9 186 14.83% | 10 713 10 043 6.67% | 8 958 9 339 -4.08% | 14 155 12 958 9.24% | 14 749 | 16 145 | 15 962 | 21 400 | 16 778 | 11 769 | 10 163 |
|
Net income Million INR | Released Forecast Spread | 4 897 3 969 23.38% | 6 131 4 436 38.21% | 3 594 5 229 -31.27% | 8 013 5 734 39.76% | 8 526 7 259 17.46% | 8 552 8 051 6.21% | 7 725 7 520 2.73% | 12 190 10 351 17.77% | 11 884 | 12 166 | 10 748 | 15 967 | 12 500 | 8 744 | 7 539 |
|
EPS INR | Released Forecast Spread | 10,7 8,27 29.68% | 13,4 9,45 41.98% | 7,86 10,4 -24.54% | 17,5 13,1 34.2% | 18,6 16,1 15.64% | 18,7 17,6 6.01% | 16,9 16,9 0.01% | 26,6 23,8 11.65% | 26,0 | 28,3 | 20,7 | 34,9 | 27,3 | 19,1 | 16,5 |
| Announcement Date | 08/11/23 | 07/02/24 | 06/05/24 | 06/08/24 | 07/11/24 | 11/02/25 | 14/05/25 | 05/08/25 | - | - | - | - | - | - | - |
| Today | Présentation aux Actionnaires / Analystes | 16:00 | |
| Today | Extraordinary General Meeting | 07:30 | |
| 09/06/2026 | Présentation aux Actionnaires / Analystes | 05:30 | |
| 09/06/2026 | Annual General Meeting | ||
| 09/06/2026 | Présentation aux Actionnaires / Analystes | 14:00 | |
| 09/06/2026 | Ex-dividend date - 0.016 CNY | 05:00 | |
| 09/06/2026 | Ex-dividend date - 0.7 CNY | 05:00 | |
| 09/06/2026 | Ex-dividend date - 0.1 CNY | 05:00 | |
| 09/06/2026 | Annual General Meeting | 02:00 | |
| 09/06/2026 | Earnings presentation | 06:00 |
Past sector events for Lupin Limited
| Today | Information meeting | 00:30 | |
| Today | Annual General Meeting | 02:00 | |
| 05/06/2026 | Présentation aux Actionnaires / Analystes | 03:30 | |
| 05/06/2026 | Annual General Meeting | 16:30 | |
| 05/06/2026 | Annual General Meeting | 02:30 | |
| 05/06/2026 | Annual General Meeting | 07:00 | |
| 05/06/2026 | Annual General Meeting | 04:00 | |
| 05/06/2026 | Extraordinary General Meeting | 03:00 | |
| 05/06/2026 | Earnings presentation | 08:00 | |
| 05/06/2026 | Présentation aux Actionnaires / Analystes | 09:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 500257 Stock
- Calendar Lupin Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















